Literature DB >> 23757003

Cultivation-dependent plasticity of melanoma phenotype.

Ondřej Kodet1, Barbora Dvořánková, Eliška Krejčí, Pavol Szabo, Petr Dvořák, Jiří Štork, Ivana Krajsová, Pavel Dundr, Karel Smetana, Lukáš Lacina.   

Abstract

Malignant melanoma is a highly aggressive tumor with increasing incidence and high mortality. The importance of immunohistochemistry in diagnosis of the primary tumor and in early identification of metastases in lymphatic nodes is enormous; however melanoma phenotype is frequently variable and thus several markers must be employed simultaneously. The purposes of this study are to describe changes of phenotype of malignant melanoma in vitro and in vivo and to investigate whether changes of environmental factors mimicking natural conditions affect the phenotype of melanoma cells and can revert the typical in vitro loss of diagnostic markers. The influence of microenvironment was studied by means of immunocytochemistry on co-cultures of melanoma cells with melanoma-associated fibroblast and/or in conditioned media. The markers typical for melanoma (HMB45, Melan-A, Tyrosinase) were lost in malignant cells isolated from malignant effusion; however, tumor metastases shared identical phenotype with primary tumor (all markers positive). The melanoma cell lines also exerted reduced phenotype in vitro. The only constantly present diagnostic marker observed in our experiment was S100 protein and, in lesser extent, also Nestin. The phenotype loss was reverted under the influence of melanoma-associated fibroblast and/or both types of conditioned media. Loss of some markers of melanoma cell phenotype is not only of diagnostic significance, but it can presumably also contribute to biological behavior of melanoma. The presented study shows how the conditions of cultivation of melanoma cells can influence their phenotype. This observation can have some impact on considerations about the role of microenvironment in tumor biology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23757003     DOI: 10.1007/s13277-013-0905-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

1.  Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.

Authors:  Rajmohan Murali; Chitra DeSilva; Stanley W McCarthy; John F Thompson; Richard A Scolyer
Journal:  Ann Surg Oncol       Date:  2012-01-21       Impact factor: 5.344

2.  The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation.

Authors:  Lisa M J Lee; Elisabeth A Seftor; Gregory Bonde; Robert A Cornell; Mary J C Hendrix
Journal:  Dev Dyn       Date:  2005-08       Impact factor: 3.780

3.  Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells.

Authors:  Petr Dvorak; Dana Dvorakova; Stanislava Koskova; Martina Vodinska; Miroslava Najvirtova; Daniel Krekac; Ales Hampl
Journal:  Stem Cells       Date:  2005-06-13       Impact factor: 6.277

4.  Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile.

Authors:  Matthew Anaka; Claudia Freyer; Craig Gedye; Otavia Caballero; Ian D Davis; Andreas Behren; Jonathan Cebon
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

5.  [The migration of pigmentary cells studies by the method of heterospecific grafts of neural tube in bird embryo].

Authors:  M A Teillet; N Le Douarin
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1970-06-22

6.  Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases.

Authors:  Simone Mocellin; Sandro Pasquali; Carlo Riccardo Rossi; Donato Nitti
Journal:  Surgery       Date:  2011-07       Impact factor: 3.982

7.  Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes.

Authors:  L Lacina; K Smetana; B Dvoránková; R Pytlík; L Kideryová; L Kucerová; Z Plzáková; J Stork; H-J Gabius; S André
Journal:  Br J Dermatol       Date:  2007-01-30       Impact factor: 9.302

8.  Dominant role of the niche in melanocyte stem-cell fate determination.

Authors:  Emi K Nishimura; Siobhán A Jordan; Hideo Oshima; Hisahiro Yoshida; Masatake Osawa; Mariko Moriyama; Ian J Jackson; Yann Barrandon; Yoshiki Miyachi; Shin-Ichi Nishikawa
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

9.  Circulating tumor cells in melanoma patients.

Authors:  Gary A Clawson; Eric Kimchi; Susan D Patrick; Ping Xin; Ramdane Harouaka; Siyang Zheng; Arthur Berg; Todd Schell; Kevin F Staveley-O'Carroll; Rogerio I Neves; Paul J Mosca; Diane Thiboutot
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

10.  High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.

Authors:  Björn Nodin; Marie Fridberg; Liv Jonsson; Julia Bergman; Mathias Uhlén; Karin Jirström
Journal:  Diagn Pathol       Date:  2012-07-17       Impact factor: 2.644

View more
  5 in total

1.  Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes.

Authors:  Njainday Pulo Jobe; Veronika Živicová; Alžběta Mifková; Daniel Rösel; Barbora Dvořánková; Ondřej Kodet; Hynek Strnad; Michal Kolář; Aleksi Šedo; Karel Smetana; Karolina Strnadová; Jan Brábek; Lukáš Lacina
Journal:  Histochem Cell Biol       Date:  2018-02-12       Impact factor: 4.304

Review 2.  Intercellular crosstalk in human malignant melanoma.

Authors:  Barbora Dvořánková; Pavol Szabo; Ondřej Kodet; Hynek Strnad; Michal Kolář; Lukáš Lacina; Eliška Krejčí; Ondřej Naňka; Aleksi Šedo; Karel Smetana
Journal:  Protoplasma       Date:  2016-11-03       Impact factor: 3.356

Review 3.  Cancer Microenvironment: What Can We Learn from the Stem Cell Niche.

Authors:  Lukas Lacina; Jan Plzak; Ondrej Kodet; Pavol Szabo; Martin Chovanec; Barbora Dvorankova; Karel Smetana
Journal:  Int J Mol Sci       Date:  2015-10-12       Impact factor: 5.923

4.  Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts.

Authors:  Ondřej Kodet; Barbora Dvořánková; Běla Bendlová; Vlasta Sýkorová; Ivana Krajsová; Jiří Štork; Jan Kučera; Pavol Szabo; Hynek Strnad; Michal Kolář; Čestmír Vlček; Karel Smetana; Lukáš Lacina
Journal:  Int J Mol Med       Date:  2018-02-01       Impact factor: 4.101

5.  Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.

Authors:  Jan Kučera; Karolína Strnadová; Barbora Dvořánková; Lukáš Lacina; Ivana Krajsová; Jiří Štork; Hana Kovářová; Helena Kupcová Skalníková; Petr Vodička; Jan Motlík; Pavel Dundr; Karel Smetana; Ondřej Kodet
Journal:  Oncol Rep       Date:  2019-09-17       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.